Peer-influenced content. Sources you trust. No registration required. This is HCN.

ConexiantChronotherapy Trial Tests Sleep Timing in Adolescents

⚠️ Small Study / Early Comparative Evidence
A University of Pittsburgh-led RCT enrolled 86 adolescents aged 16 to 19 with habitual weekend sleep onset after 1:00 AM, randomizing them to the Sleeping Late Teens Program or a sleep-monitoring control. The intervention combined collaborative problem-solving, personalized sleep scheduling, morning bright-light glasses, and evening blue light–blocking glasses over 2 weeks.


Clinical Considerations

  • Salivary dim-light melatonin onset advanced 45 minutes in the intervention group relative to controls, a primary outcome.
  • Weeknight sleep duration increased by 47 minutes versus controls, with mean weekday sleep rising from 6.48 to 7.27 hours in the intervention arm.
  • Circadian alignment (DLMO-to-midsleep interval) did not significantly differ between groups, leaving one of three primary outcomes unmet.
  • Adherence varied by component, ranging from 63% for earlier bedtimes to 79% for morning bright-light glasses, with no reported adverse events.

Practice Applications

  • Consider sleep timing and light exposure counseling for adolescents reporting delayed sleep patterns, even before pharmacologic options.
  • Recognize that the intervention shifted timing and duration but did not improve circadian alignment over 2 weeks.
  • Interpret findings cautiously given short follow-up, modest sample, predominantly White cohort, and confounding from text reminders, incentives, and staff contact.
  • Monitor for lower-cost translation options such as natural daylight exposure, school lighting adjustments, and screen filters as the evidence base matures.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form